Conversely, GUSBP11 expression correlates with better prognosis in head and neck squamous cell carcinoma [82], bladder cancer [83], papillary renal cell carcinoma [84], and pancreatic adenocarcinoma [85]. This evidence concerns the gene GUSBP11 and urinary bladder carcinoma.